Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > If you read my posts in August

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Jan 02, 2020 3:27pm

98 Views

Post# 30512317

RE:RE:If you read my posts in August

Riplazym? Pandorum marcjohnson Newcamo Realstocky Moneyman all the same guy spelling Ryplazim wrong... hilarious if not such a pathetic pumper

marcjohnson wrote:

i partially agree with you, but they are developing the assets to get the max they can get out of lmnl...that's their exit point and how they get paid! At very least riplazym and several indications of pbi4050, that is all ongoing and timeframed, once this is done lmnl will be merged or acquired, if they are successful, i see, like others here, between 50-100$ BEFORE merging or acquisition of the company. This tripled last week...it will move and reflect proper business value...

At minimum, this will go at around 100$ when all done.